NEW YORK, NY, December 07, 2023 – PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Kamada Ltd. (Nasdaq: KMDA), a commercial-stage global biopharmaceutical company with a portfolio of products for rare and serious conditions and a leader in the specialty plasma-derived field, today announced it has inked its largest commercial agreement to date, set … Continue reading PRISM MarketView Biotech Index Top Mover Spotlight: Kamada (KMDA)